Please enable Javascript to get a taste of that Hopium 👼

AVIR - Financials Overview - Atea Pharmaceuticals Inc


We've grouped the latest 4 financial reports for AVIR. You can view and compare their Income Statement, Balance Sheet, and Cash Flow.

Income Statement2020
Total Revenue$48.6M
Cost of Revenue$21.7M
Gross Margin$27.0M
Research & Development$38.0M
Selling, General and Administrative-
Other Operating Expense-
Total Operating Expense-
Operating Income-$11.0M
Interest Income$83.0K
Interest Expense-
Net Interest Incomee$83.0K
Other Income Expense-
Non-recurring Items-
Other Non-operating Income$83.0K
Income before Provision for income taxes-$10.9M
Tax Provision-
Net Income-$10.9M
Effect of accounting charges-
Minority Interest-
Provision for income taxes-
Non-recurring items-
Other Items-
Discontinued Operations-
Preferred Stock Dividends-
Balance Sheet20192020
Cash, Cash Equivalents & Short-term investments$21.7M$850.12M
Cash & Cash Equivalents--
Other Short-term Investments--
Other Current Assets$249K$7.55M
Total Current Assets$21.9M$863.48M
Non-current Marketable Securities--
total non-current assets$163K$155K
Other Intangible Assets--
deferred long-term asset charges--
Total Assets$22.1M$863.63M
Accounts Payable--
Current Debt--
Other Current Liabilties$1.89M$14.4M
Total Current Liabilities$2.44M$316M
Long Term Debt--
Non-Current Deferred Liabilties--
Negative Goodwill--
Other Non-Current Liabilities$95.0K$36.0K
total non-current liabilities$69.2M$36.0K
Total capital lease obligations--
Total Liabilities$2.53M$316M
Shareholder's Equity
Common Stock--
Share premium--
Preferred Stock--
Retained Earnings--
Additional Paid-in Capital--
Gains/Losses not affecting retained earnings--
Treasury Stock--
Total Shareholders' Equity$19.5M$547.8M
Total Liabilities and Shareholders' Equity--
Cash Flow2020
Cash from Operating Activities
Operating Activities$297M
Other Operating Activities-
Change(increase) in Operating Activities-
Net Income-$10.9M
Change in Liabilities-
Change in Inventory-
Change(increase) in Account Receivables-
Change(increase) in Receivables$5.82M
Cash from Investing Activities
Investment Activities-$26.0K
Other Investment Activities-
Capital Expenditures$26.0K
Cash from Financing Activities
Financing Activities$531.75M
Other Financing Activities-
Stock Sale and Purchase-
Net Borrowings-
Change(increase) in Cash-
Change(increase) in Cash and Cash Equivalents$828.46M
Change(increase) in Net Income-
Change in Exchange Rate-
Data source(s): Alpha Vantage